The presence of CGRP in the central, as well as the peripheral nervous system and its defined role in the pathogenesis of migraine (retrograde pathway from the ganglion of the fifth cranial nerve to the brain after internalization), is now able to guide researchers towards the role of agents targeting this neuropeptide. This evidence concerns the gene CALCA and migraine disorder.